Safety of etanercept therapy in rheumatoid patients undergoing surgery: preliminary report
Abstract This is a preliminary report on a case-series of rheumatoid patients that underwent various kinds of elective surgery but did not withdraw etanercept therapy in spite of physician advise. Elective surgery consisted of right knee surgical prosthesis, bilateral cataract, bilateral hallux valgus, right hip prosthesis, bladder stone by cystoscopy and left inguinal hernia. All the patients had a regular healing rate. During follow-up (6–12 months) no one of these patients were suffering from infective complications after surgery. According to same recent literature results, our data suggest that it is the time to value rheumatoid patient preferences through a correct information about cost-benefit of this treatment to establish together with patients if etanercept therapy has to be discontinued before and after elective surgery. Finally, we think that adverse drug reaction surveillance has to be boosted, and editors of leading scientific journal should publish more papers on case-series about drug safety and tolerability in particular conditions..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2007 |
|---|---|
| Erschienen: |
2007 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Clinical rheumatology - 26(2007), 9 vom: 17. Jan., Seite 1513-1515 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Corrao, Salvatore [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Anti-rheumatic agents |
| doi: |
10.1007/s10067-007-0534-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR008494983 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR008494983 | ||
| 003 | DE-627 | ||
| 005 | 20230520004021.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201005s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10067-007-0534-0 |2 doi | |
| 035 | |a (DE-627)SPR008494983 | ||
| 035 | |a (SPR)s10067-007-0534-0-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.00 |2 bkl | ||
| 084 | |a 44.83 |2 bkl | ||
| 100 | 1 | |a Corrao, Salvatore |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Safety of etanercept therapy in rheumatoid patients undergoing surgery: preliminary report |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract This is a preliminary report on a case-series of rheumatoid patients that underwent various kinds of elective surgery but did not withdraw etanercept therapy in spite of physician advise. Elective surgery consisted of right knee surgical prosthesis, bilateral cataract, bilateral hallux valgus, right hip prosthesis, bladder stone by cystoscopy and left inguinal hernia. All the patients had a regular healing rate. During follow-up (6–12 months) no one of these patients were suffering from infective complications after surgery. According to same recent literature results, our data suggest that it is the time to value rheumatoid patient preferences through a correct information about cost-benefit of this treatment to establish together with patients if etanercept therapy has to be discontinued before and after elective surgery. Finally, we think that adverse drug reaction surveillance has to be boosted, and editors of leading scientific journal should publish more papers on case-series about drug safety and tolerability in particular conditions. | ||
| 650 | 4 | |a Anti-rheumatic agents |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Etanercept |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Patient satisfaction |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Rheumatoid arthritis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Surgery |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Pistone, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Arnone, Sabrina |e verfasserin |4 aut | |
| 700 | 1 | |a Calvo, Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a Scaglione, Rosario |e verfasserin |4 aut | |
| 700 | 1 | |a Licata, Giuseppe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical rheumatology |d London : Springer, 1982 |g 26(2007), 9 vom: 17. Jan., Seite 1513-1515 |w (DE-627)SPR008480389 |w (DE-600)1480901-1 |x 1434-9949 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2007 |g number:9 |g day:17 |g month:01 |g pages:1513-1515 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10067-007-0534-0 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.00 |q ASE |
| 936 | b | k | |a 44.83 |q ASE |
| 951 | |a AR | ||
| 952 | |d 26 |j 2007 |e 9 |b 17 |c 01 |h 1513-1515 | ||